Maintained efficacy of the tyrosine kinase inhibitor imatinib mesylate in a patient with rheumatoid arthritis

J Clin Rheumatol. 2008 Oct;14(5):294-6. doi: 10.1097/RHU.0b013e318188b1ce.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Arthritis, Rheumatoid / drug therapy*
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Male
  • Pain Measurement
  • Piperazines / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Treatment Outcome

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate